Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

Becton Dickinson and Co (BDX) stock saw a decline, ending the day at $232.59 which represents a decrease of $-3.21 or -1.36% from the prior close of $235.8. The stock opened at $237 and touched a low ...

EVP Shana Carol Neal sold 788 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an ...

Charting, Price Performance, News & Related Contracts.

Charting, Price Performance, News & Related Contracts.

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...

Becton, Dickinson & Co shares are currently trading up about 1.1% on the day. The chart below shows the one year performance of BDX shares, versus its 200 day moving average: ...

In a recent transaction, Shan David, Executive Vice President and Chief ISC Officer at Becton Dickinson & Co (NYSE:BDX), sold ...

Becton, Dickinson and Company BDX, popularly known as BD ... The optimism led by a solid fourth-quarter fiscal 2024 performance and a few strategic deals are expected to contribute further.